rituximab

Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?

Number 21

Impact Factor 1 November 2007 0

A study by the German Low Grade Lymphoma Study Group has shown that rituximab maintenance following salvage with rituximab-containing chemotherapy is the standard of care for advanced-stage refractory or relapsed follicular lymphoma. Download full article

Factors predictive for response of follicular and mantle cell lymphoma to rituximab

Number 13

Impact Factor 1 July 2006 0

A recent analysis of prognostic factors may help identify which follicular and mantle cell lymphoma patients should be excluded from trials of single-agent rituximab therapy. Download full article